跳至主要内容
临床试验/NL-OMON48755
NL-OMON48755撤回不适用

The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot Study - MINT 1 Study

RCSI Clinical Research Centre, Royal College of Surgeons in Ireland0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • 1) Gestational age *34 weeks and birth weight *2000 grams
  • 2) * 10 postnatal days of life and within 4 days of admission
  • 3) Echocardiographic diagnosis of PPHN
  • 4) Absence of significant congenital heart defect excluding a small atrial
  • septal defect or ventricular septal defect (measuring< 3mm)
  • 5) Oxygenation index of * 10

排除标准

  • 1) Lethal congenital anomalies or obvious syndrome
  • 2) Bleeding diathesis (abnormal coagulation screen/platelet <100,000/ mm3)
  • 3) The presence of Intraventricular haemorrhage.
  • 4) Diastolic Hypotension (defined as a diastolic blood pressure less than the
  • 3rd centile for any given gestation) unresponsive to medical treatment (*30
  • mL/kg fluid bolus and * 2 inotropes of at least 10 *g/ kg/min)
  • 5) Hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia
  • 6) Evidence of renal impairment (Creatinine > 100micromol/l)
  • 7) Severe Hypovolaemia: Heart rate > 180, capillary refill > 5 seconds, urine
  • output < 0.5ml/kg/hour, in addition to diastolic hypotension mentioned above.

研究者

发起方
RCSI Clinical Research Centre, Royal College of Surgeons in Ireland

相似试验

The Use of Milrinone in Neonates with Persistent... | 临床试验